Concentric Capital Strategies’s Eli Lilly LLY Stock Holding History

Concentric Capital Strategies’s Portfolio LLY Stock Details LLY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.22M	Sell	1,849 -158	-8%	-$161K	0.12%	165
2026 Q1	$1.85M	Buy	2,007 +1,159	+137%	+$1.18M	0.16%	106
2025 Q4	$911K	Buy	848 +33	+4%	+$31.6K	0.04%	208
2025 Q3	$622K	Sell	815 -25	-3%	-$18.6K	0.03%	236
2025 Q2	$655K	Buy	+840	New	+$653K	0.03%	240
2025 Q1	–	Sell	-5,058	Closed	-$3.9M	–	239
2024 Q4	$3.9M	Sell	5,058 -15,052	-75%	-$12.5M	0.18%	113
2024 Q3	$17.8M	Buy	20,110 +1,991	+11%	+$1.79M	0.73%	21
2024 Q2	$16.4M	Buy	18,119 +12,673	+233%	+$10.1M	0.82%	18
2024 Q1	$4.24M	Buy	+5,446	New	+$3.88M	0.24%	103
2023 Q4	–	Sell	-947	Closed	-$509K	–	280
2023 Q3	$509K	Buy	+947	New	+$488K	0.05%	161

Other funds holding LLY

Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

PNC Financial Services Group Pittsburgh, Pennsylvania $202B AUM 37.79% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Concentric Capital Strategies's LLY Position: Q2 2026 in Review

Concentric Capital Strategies reduced its Eli Lilly (LLY) stake by 7.9% in Q2 2026, selling an estimated $161K and leaving 1,849 shares worth $2.22M. The position accounts for 0.12% of the portfolio, ranked #165.

Concentric Capital Strategies first reported a position in LLY in Q3 2023 and has held it in 10 quarters since. The position peaked at $17.8M in Q3 2024. 4,642 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

Concentric Capital Strategies held 1,849 shares of Eli Lilly worth $2.22M as of Q2 2026.
Concentric Capital Strategies sold 158 Eli Lilly shares in Q2 2026, an estimated $161K.
Eli Lilly made up 0.12% of Concentric Capital Strategies's portfolio in Q2 2026, its #165 holding.
Concentric Capital Strategies first reported a position in Eli Lilly in Q3 2023 and has held it in 10 quarters since.
Concentric Capital Strategies's Eli Lilly position peaked at $17.8M in Q3 2024.
4,642 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Concentric Capital Strategies's 13F filing for Q2 2026, filed 14 Aug 2026.